Liposomal resiquimod for the treatment of Leishmania donovani infection

OBJECTIVES: The imidazoquinoline family of drugs are Toll-like receptor 7/8 agonists that have previously been used in the treatment of cutaneous leishmaniasis. Because of the hydrophobic nature of imidazoquinolines, they are traditionally not administered systemically for the treatment of visceral...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Peine, Kevin J., Gupta, Gaurav, Brackman, Deanna J., Papenfuss, Tracey L., Ainslie, Kristy M., Satoskar, Abhay R., Bachelder, Eric M.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2014
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3861330/
https://ncbi.nlm.nih.gov/pubmed/23956375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkt320
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires